![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: KIAA1328 |
Gene summary for KIAA1328 |
![]() |
Gene information | Species | Human | Gene symbol | KIAA1328 | Gene ID | 57536 |
Gene name | KIAA1328 | |
Gene Alias | KIAA1328 | |
Cytomap | 18q12.2 | |
Gene Type | protein-coding | GO ID | GO:0003674 | UniProtAcc | Q86T90 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
57536 | KIAA1328 | RNA-P17T-P17T-2 | Human | Lung | IAC | 2.13e-03 | 4.18e-01 | 0.3371 |
57536 | KIAA1328 | RNA-P17T-P17T-4 | Human | Lung | IAC | 4.71e-02 | 3.87e-01 | 0.343 |
57536 | KIAA1328 | RNA-P17T-P17T-6 | Human | Lung | IAC | 4.71e-02 | 3.86e-01 | 0.3385 |
57536 | KIAA1328 | RNA-P23T2-P23T2-1 | Human | Lung | MIAC | 2.13e-03 | 7.54e-01 | -0.037 |
57536 | KIAA1328 | RNA-P23T2-P23T2-4 | Human | Lung | MIAC | 9.90e-04 | 9.22e-01 | -0.0272 |
57536 | KIAA1328 | RNA-P25T1-P25T1-1 | Human | Lung | AIS | 1.49e-13 | 6.24e-01 | -0.2116 |
57536 | KIAA1328 | RNA-P25T1-P25T1-2 | Human | Lung | AIS | 9.39e-09 | 7.88e-01 | -0.1941 |
57536 | KIAA1328 | RNA-P25T1-P25T1-3 | Human | Lung | AIS | 4.20e-06 | 5.48e-01 | -0.2107 |
57536 | KIAA1328 | RNA-P25T1-P25T1-4 | Human | Lung | AIS | 2.01e-09 | 5.81e-01 | -0.2119 |
57536 | KIAA1328 | RNA-P6T2-P6T2-1 | Human | Lung | IAC | 2.10e-09 | 3.71e-01 | -0.0166 |
57536 | KIAA1328 | RNA-P6T2-P6T2-2 | Human | Lung | IAC | 6.53e-06 | 2.56e-01 | -0.0132 |
57536 | KIAA1328 | RNA-P6T2-P6T2-3 | Human | Lung | IAC | 3.91e-04 | 2.09e-01 | -0.013 |
57536 | KIAA1328 | RNA-P6T2-P6T2-4 | Human | Lung | IAC | 5.70e-05 | 2.46e-01 | -0.0121 |
57536 | KIAA1328 | RNA-P7T1-P7T1-3 | Human | Lung | AIS | 1.01e-04 | 5.59e-01 | -0.0822 |
57536 | KIAA1328 | RNA-P7T1-P7T1-4 | Human | Lung | AIS | 2.35e-06 | 5.45e-01 | -0.0809 |
57536 | KIAA1328 | HTA12-15-2 | Human | Pancreas | PDAC | 4.92e-06 | 4.69e-01 | 0.2315 |
57536 | KIAA1328 | HTA12-23-1 | Human | Pancreas | PDAC | 1.89e-07 | 7.57e-01 | 0.3405 |
57536 | KIAA1328 | HTA12-25-1 | Human | Pancreas | PDAC | 2.44e-10 | 9.01e-01 | 0.313 |
57536 | KIAA1328 | HTA12-26-1 | Human | Pancreas | PDAC | 3.84e-16 | 8.50e-01 | 0.3728 |
57536 | KIAA1328 | HTA12-29-1 | Human | Pancreas | PDAC | 2.70e-40 | 9.00e-01 | 0.3722 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Lung | ![]() | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ | ||
IAC: Invasive lung adenocarcinoma | ||
MIA: Minimally invasive adenocarcinoma |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
KIAA1328 | SNV | Missense_Mutation | c.1016G>C | p.Arg339Pro | p.R339P | Q86T90 | protein_coding | tolerated(0.23) | benign(0.284) | TCGA-DD-A114-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
KIAA1328 | SNV | Missense_Mutation | c.987N>C | p.Lys329Asn | p.K329N | Q86T90 | protein_coding | tolerated(0.25) | benign(0.007) | TCGA-DD-A4NO-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
KIAA1328 | SNV | Missense_Mutation | rs751677814 | c.1514N>A | p.Thr505Asn | p.T505N | Q86T90 | protein_coding | tolerated(0.39) | benign(0) | TCGA-05-4397-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
KIAA1328 | SNV | Missense_Mutation | c.550G>A | p.Gly184Ser | p.G184S | Q86T90 | protein_coding | tolerated(0.75) | benign(0.116) | TCGA-05-4410-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
KIAA1328 | SNV | Missense_Mutation | c.1440N>G | p.Asp480Glu | p.D480E | Q86T90 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-62-8398-01 | Lung | lung adenocarcinoma | Male | <65 | III/IV | Chemotherapy | carboplatin | CR | |
KIAA1328 | SNV | Missense_Mutation | novel | c.390N>A | p.Phe130Leu | p.F130L | Q86T90 | protein_coding | deleterious(0) | benign(0.09) | TCGA-62-A470-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
KIAA1328 | SNV | Missense_Mutation | c.1048N>A | p.Gly350Arg | p.G350R | Q86T90 | protein_coding | tolerated(0.55) | benign(0.003) | TCGA-18-5592-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
KIAA1328 | SNV | Missense_Mutation | novel | c.251G>T | p.Gly84Val | p.G84V | Q86T90 | protein_coding | deleterious(0.02) | possibly_damaging(0.79) | TCGA-85-8666-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
KIAA1328 | SNV | Missense_Mutation | novel | c.227N>C | p.Val76Ala | p.V76A | Q86T90 | protein_coding | tolerated(0.23) | benign(0.007) | TCGA-CV-5432-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
KIAA1328 | SNV | Missense_Mutation | novel | c.958N>T | p.Pro320Ser | p.P320S | Q86T90 | protein_coding | tolerated(0.44) | benign(0.007) | TCGA-CV-5432-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |